Back to Trials
NCT06666608NARecruiting

Bone Stimulator for Spondylolysis

The Methodist Hospital Research Institute

Start Date

12/3/2025

Completion Date

12/1/2029

Summary

This prospective study aims to investigate the effectiveness of bone stimulator therapy as adjunct treatment of spondylolysis in athletic populations. By evaluating its impact on pain reduction, functional improvement, osseous bony union and return-to-sport time, the investigators seek to provide valuable insights into the role of bone stimulation therapy as a potential treatment modality for this challenging condition.

Eligibility Criteria

Age Range: 16 years to 40 years

Inclusion Criteria: * Patients between the ages of 16 to 40 years of age diagnosed with symptomatic spondylolysis by one of the investigators * Patients who plan to attend prescribed physical therapy * Patients who participate in a regular sport whether that be professional, collegiate or recreational Exclusion Criteria: * Any condition which in the investigator's opinion, would interfere with the subject's ability to comply with study instructions * Patients with contraindications to bone stimulator therapy * Patients with pacemaker and implantable cardioverter defibrillator * Patients with previous spine surgery * Patients with metabolic bone conditions * Patients who use nicotine products * Vulnerable populations * Non-English speaking services

Interventions

DEVICE

Bone Stimulator

OTHER

Standard of Care Spondylolysis Treatment

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

SpondylolysisSymptomatic SpondylolysisAthletes

Locations

Houston Methodist Hospital

Houston, Texas 77030

United States